Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the REEP6 gene.
Features include always present findings: Nyctalopia, Reduced visual acuity, Rod-cone dystrophy, and Attenuation of retinal blood vessels and others; and common findings: Constriction of peripheral visual field, Bone spicule pigmentation of the retina, and Posterior subcapsular cataract. 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 4 | Cystoid macular edema, Posterior subcapsular cataract, Attenuation of retinal blood vessels |
REEP6 function has not been fully characterized.
Retinitis pigmentosa 77 is associated with mutations in the REEP6 gene on chromosome 19.
Genetic testing for REEP6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 77 has been reported in the published literature.
Phenotype severity distribution: 5 always present features, 3 common features.
No clinical trials have been registered for retinitis pigmentosa 77.
34 publications have been identified in PubMed for retinitis pigmentosa 77. Research spans Epidemiology / Natural History (41%), Diagnostic / Biomarker (21%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 14 | 41% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 3:04 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Bones and joints | 1 | Bone spicule pigmentation of the retina |
Muscles | 1 | Retinal atrophy |
Testing and diagnosis research
7 |
21% |
Patient case studies | 5 | 15% |
Laboratory research | 4 | 12% |
Research summaries | 2 | 6% |
Clinical study results | 1 | 3% |
New treatment approaches | 1 | 3% |
Shah M (2026). [PMID: 40690992](https://pubmed.ncbi.nlm.nih.gov/40690992/). *Clin Exp Optom*. [Gene Therapy / Novel Therapeutics]
Zhu X (2026). [PMID: 41908299](https://pubmed.ncbi.nlm.nih.gov/41908299/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Yang Y (2026). [PMID: 41017685](https://pubmed.ncbi.nlm.nih.gov/41017685/). *Neural Regen Res*. [Basic Science / Preclinical]
Polat G (2026). [PMID: 41996232](https://pubmed.ncbi.nlm.nih.gov/41996232/). *Cesk Slov Oftalmol*. [Case Report / Case Series]
Hong Y (2026). [PMID: 41242591](https://pubmed.ncbi.nlm.nih.gov/41242591/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Marsal-Olivan A (2026). [PMID: 42071123](https://pubmed.ncbi.nlm.nih.gov/42071123/). *J Assist Reprod Genet*. [Diagnostic / Biomarker]
Benites-Narcizo G (2026). [PMID: 42194903](https://pubmed.ncbi.nlm.nih.gov/42194903/). *J Clin Med*. [Review / Meta-Analysis]
Tsuboi T (2026). [PMID: 41553438](https://pubmed.ncbi.nlm.nih.gov/41553438/). *Jpn J Ophthalmol*. [Epidemiology / Natural History]
Eriksen KO (2026). [PMID: 40977613](https://pubmed.ncbi.nlm.nih.gov/40977613/). *Acta Ophthalmol*. [Epidemiology / Natural History]
Wei Q (2025). [PMID: 40051895](https://pubmed.ncbi.nlm.nih.gov/40051895/). *Int J Gen Med*. [Diagnostic / Biomarker]